Free Trial
ASX:ADN

Andromeda Metals (ADN) Stock Price, News & Analysis

Andromeda Metals logo

About Andromeda Metals Stock (ASX:ADN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
6.96 million shs
Average Volume
N/A
Market Capitalization
$27.41 million
P/E Ratio
N/A
Dividend Yield
2.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Andromeda Metals Limited, together with its subsidiaries, operates as a mineral exploration company in Australia. It explores for halloysite, kaolin, gold, and copper deposits. The company's primary project is the Great White and Mount Hope Kaolin project located in the Eyre Peninsula in South Australia. It also holds interests in the Drummond Epithermal Gold Project located in Drummond Basin, North Queensland; and the Eyre Peninsula Gold, Eyre Kaolin Project, Camel Lake Halloysite Project, and Moonta Copper Gold Project located in South Australia. The company was formerly known as Adelaide Resources Limited and changed its name to Andromeda Metals Limited in December 2016. Andromeda Metals Limited was incorporated in 1993 and is headquartered in Adelaide, Australia.

Receive ADN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Andromeda Metals and its competitors with MarketBeat's FREE daily newsletter.

ADN Stock News Headlines

Director Changes at Andromeda Metals Limited
A deadly mistake in my prediction…
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Andromeda Metals Secures $2.34M R&D Tax Refund
Andromeda Metals Appoints New Director
See More Headlines

ADN Stock Analysis - Frequently Asked Questions

Andromeda Metals Limited (ASX:ADN) posted its quarterly earnings results on Tuesday, March, 13th. The company reported $0.00 earnings per share for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Andromeda Metals investors own include Artemis Resources (ARV), AstraZeneca (AZN), DocuSign (DOCU), Estée Lauder Companies (EL), Grafton Group (GFTU), Barrick Gold (GOLD) and HSBC (HSBA).

Company Calendar

Last Earnings
3/13/2018
Today
3/03/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Other Industrial Metals & Mining
Sub-Industry
Electrical Equipment
Current Symbol
ASX:ADN
CIK
N/A
Fax
N/A
Employees
200
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,560,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2 million
Price / Cash Flow
17.67
Book Value
A$0.05 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
3,390,000,000
Free Float
N/A
Market Cap
$27.41 million
Optionable
Not Optionable
Beta
1.59
Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (ASX:ADN) was last updated on 3/3/2025 by MarketBeat.com Staff
From Our Partners